Clinical Trials Directory

Trials / Completed

CompletedNCT06505408

Impact of a MVM to Support Biomarkers Associated With Conception and Pregnancy in Healthy Women.

Evaluating the Impact of a Multivitamin Supplement to Support Biomarkers Associated With Conception and Pregnancy in Healthy Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Perelel Inc. · Industry
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to investigate the effects multivitamin (MVM) on blood biomarkers that are associated with healthy pregnancy and conception in adult women. The main question it aims to answer is: Is there a significant change in blood biomarkers from baseline (week 0) to end of intervention (week 12) in healthy women consuming multivitamin compared to participants consuming the placebo product? Participants will: Take drug MVM or a placebo every day for 12 weeks Visit the clinic at baseline and 12 weeks for serum blood draws and measurements Complete a series of surveys at baseline and 12 weeks

Detailed description

A 12 week double-blind, placebo-controlled, clinical trial assessing the daily administration of a multivitamin (MVM) or placebo on blood biomarkers associated with healthy pregnancy and conception in healthy adult women. Participants will consume study product or placebo for 12 weeks. Measurements will be taken at baseline and at the end of 12 weeks. Primary Objective: To evaluate in healthy women, the effect of 12-week long daily administration of a multivitamin (MVM) on blood biomarkers associated with healthy pregnancy (Folate). Secondary Objective: To evaluate in healthy women, the effect of 12-week long daily administration of multivitamin (MVM) on blood biomarkers associated with healthy pregnancy * Vitamin B12 * Iron * Omega-3 * Choline * CoQ10

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMultivitamin4 capsules of Perelel Health Conception Support Multivitamin Pack (consisting of vitamins, minerals, and omega ingredients) consumed daily for 12 weeks
DIETARY_SUPPLEMENTPlacebo4 placebo capsules consumed daily for 12 weeks

Timeline

Start date
2024-10-02
Primary completion
2025-01-20
Completion
2025-01-20
First posted
2024-07-17
Last updated
2025-06-06

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT06505408. Inclusion in this directory is not an endorsement.